Dr. Dionysios Christos Watson, MD

Dr. Watson practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Watson's NPI, 1669913018, was assigned on March 19, 2017. Dr. Watson graduated from University of Patras School of Medicine in 2011. Dr. Watson holds Florida license ME161651.

Dr. Watson's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Watson's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Watson is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Watson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watson practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Watson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Watson is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Watson's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists colorectal cancer among the conditions Dr. Watson treats.

CMS data shows 91 Medicare services from Dr. Watson across 2 procedure codes in 2024, for 30 Medicare patients. Medicare paid $4,538 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. Watson in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Watson's median patient age at 70, with 28% women.

In 2024, Dr. Watson wrote 95 Medicare Part D claims for 20 patients. 88% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $103 in total drug cost. In 2019, CMS named 81 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Watson for performance year 2024, reported as part of a group. Dr. Watson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Watson as offering telehealth.

Dmand AI links 18 papers to Dr. Watson, published from 2017 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Glioblastoma, Extracellular Vesicles and Immunotherapy. Dr. Watson has published most often in Cancer Discov. Dr. Watson's most frequent co-authors are Matthew M. Grabowski, Manmeet Singh Ahluwalia, MD and Antonio Valentin, MD.

CMS Open Payments shows 13 general payments to Dr. Watson from 8 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $243.

Dr. Watson graduated from University of Patras School of Medicine in 2011.

Dr. Watson is in network with 10 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.